LENZ Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LENZ Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q2 2024.
  • LENZ Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.73M, a 89.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.73M -$14.1M -89.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $578K -$3.44M -85.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $318K -$5.26M -94.3% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $13.2M +$6.08M +85.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $15.8M +$7.2M +83.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.01M -$6.11M -60.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.58M -$5.99M -51.8% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $7.12M -$1.96M -21.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $8.64M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $10.1M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $11.6M Dec 31, 2021 10-K 2023-03-20
Q3 2021 $9.08M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.